Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer

2022-01-18T13:26:03+00:00January 18th, 2022|

Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer Overall Survival CONTACT US Summary This study investigates the [...]

Efficacy of Dendritic Cell-Cytokine Induced Killer Cells combined with concurrent chemoradiotherapy on Locally Advanced Non- Small Cell Lung Cancer (LANSCLC)

2022-01-04T06:53:36+00:00January 1st, 2022|

Efficacy of Dendritic Cell-Cytokine Induced Killer Cells combined with concurrent chemoradiotherapy on Locally Advanced Non- Small Cell Lung Cancer (LANSCLC) Survival Time CONTACT US Summary This study aims to [...]

A clinical study evaluating dendritic and cytokine-induced killer cells combined with concurrent radiochemotherapy for stage IIIB non-small cell lung cancer

2021-12-29T17:52:45+00:00December 29th, 2021|

A clinical study evaluating dendritic and cytokine-induced killer cells combined with concurrent radiochemotherapy for stage IIIB non-small cell lung cancer Non-small cell lung cancer: Adenocarcinoma CONTACT US Summary The [...]

Randomized controlled phase III trial of adjuvant chemo‐immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer

2021-12-23T11:36:32+00:00December 23rd, 2021|

Randomized controlled phase III trial of adjuvant chemo‐immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer Recurrence-free Survival CONTACT US Summary A [...]

The combination of Dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors

2021-12-16T07:30:27+00:00December 16th, 2021|

The combination of Dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors Detection of CIKs,CTLs and intracellular IFN-Y in T cells by flow cytometry [...]

Go to Top